Role of the cholesteryl ester transfer protein (CETP) in retinoid-associated dyslipidemias in patients treated for cuteanous disorders.
- Conditions
- 10013317dyslipidemiahypoHDLemia
- Registration Number
- NL-OMON29950
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 25
Inclusion Criteria
People suffering from severe forms of acne or psoriasis requiring a treatment with Roaccutane or Neotigason, but who did not start with the treatment yet.
Exclusion Criteria
Treatment with hypolipidemic or antidiabetic drugs.
Hepatic disorders
Alcoholism
Diabetes
Acute infection
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>- CETP activity : fluorescent kinetics in microplates<br /><br>- Plasma CETP concentration : enyme-linked immunosorbent assay (ELISA)</p><br>
- Secondary Outcome Measures
Name Time Method <p>- Plasma lipid levels (cholesterol, phospholipids, triglycerides): enzymatic<br /><br>assays<br /><br>- Cholesterol and triglyceride distribution between lipoprotein classes, and<br /><br>HDL size : fast protein liquid chromatography (FPLC) non-denaturing<br /><br>electrophoresis.</p><br>